A Guide to Your Regenerative Treatment Options for Pelvic Pain

Chronic pelvic pain syndrome (CPPS), pelvic floor disorders (PFDs), and conditions such as interstitial cystitis represent some of the most complex clinical challenges in modern urology and gynecology. Regenerative medicine is fundamentally changing the approach to pelvic pain treatment. By focusing on the cellular drivers of pelvic dysfunction, including neuroinflammation and muscle loss, researchers are investigating how the latest stem cell treatments can help rehabilitate damaged pelvic tissue.

Whether stemming from musculoskeletal trauma, childbirth injuries, surgical mesh complications, or neuro-inflammatory disease, severe pelvic distress dramatically diminishes a patient’s quality of life. The latest research shows that 1 in 7 women of childbearing age experience pelvic pain that has endured for six months or longer.

Standard care protocols, ranging from opioid-based analgesics and nerve blocks to invasive reconstructive surgeries, frequently prioritize symptom management over functional healing. Surgical interventions carry significant risks of scar tissue formation and long-term anatomical distortion.

This post presents the latest data on treatments for pelvic pain and explains what you need to know in choosing the best treatment approach for you.

An Introduction to Cellular Therapies for Pelvic Pain

For relieving pelvic distress, regenerative cellular therapies help modulate immune overactivity, stimulate tissue repair, and encourage vascularization in damaged pelvic ligaments and sphincter muscles. By rehabilitating the local microenvironment, these treatments can offer a scientifically distinct pathway from traditional surgical and pharmaceutical options. Mesenchymal Stem Cells (MSCs) and advanced Dezawa MuseCells™ represent two leading regenerative care options for those experiencing chronic pelvic pain.

The Role of Neuroinflammation and Muscular Deficits

Persistent pelvic discomfort is rarely just a mechanical issue. Modern investigations highlight neuro-immune dysregulation as a primary instigator.

In patients experiencing Chronic Pelvic Pain Syndrome (CPPS) or post-surgical pelvic trauma, the localized immune response remains in a hyperactive, pro-inflammatory state. This ongoing inflammatory environment prevents muscle fibers, fascia, and local nerves from healing appropriately.

Cellular therapies can help bridge this gap. By addressing both the chronic inflammatory loop and structural deficits, they initiate tissue repair in the pelvic floor musculature rather than simply masking the pain.

Pelvic Pain Conditions for Which Cellular Therapies May Be Suitable

Pelvic floor dysfunction

Symptoms of pelvic floor dysfunction include aching or heaviness in the pelvis, muscle spasms, pain during intercourse, and difficulty emptying the bowels or bladder (frequently resulting in stress incontinence).

A systematic review of stem cell trials for pelvic floor disorders has found that stem cells support the functional regeneration of damaged sphincter muscles.

Endometriosis

Patients with endometriosis experience severe menstrual cramps, deep pain during sexual intercourse, chronic lower back or pelvic ache, and heavy or irregular bleeding.

The data show adipose-derived stem cell injections can help reduce endometriotic lesion progression and inflammation.

You can read more about the role of stem cell treatments for endometriosis pain in our recent treatment guide.

Pudendal Neuralgia

The symptoms associated with pudendal neuralgia include severe burning, crushing, shooting, or prickling pain in the perineum, rectum, or genitals that worsens with sitting.

In animal studies, the research has shown that injecting MSCs into subjects with bilateral pudendal nerve damage successfully promoted connective tissue regeneration and improved peripheral nerve repair.

Understanding Your Pelvic Pain Relief Options: MSCs vs. Dezawa MuseCells™

Both therapies offer significant restorative benefits for patients with pelvic pain, but they operate through slightly different biological mechanisms and capabilities.

Mesenchymal Stem Cells (MSCs)

MSCs are multipotent adult stem cells typically sourced from bone marrow or adipose (fat) tissue. They have become the foundational standard in regenerative medicine for orthopedic and pelvic injuries.

• Paracrine Signaling

MSCs function primarily by improving the local tissue environment. They release powerful biochemical signals (cytokines and growth factors) that instruct your body’s existing cells to reduce inflammation and repair damaged tissue.

• Immunomodulation

They actively downgrade aggressive immune cells, rebalancing the hostile environment that can cause chronic pelvic aching.

Dezawa MuseCells™

MuseCells (Multilineage-Differentiating Stress-Enduring Cells) are a unique subpopulation of stem cells. STEMS Health utilizes Dezawa MuseCells™, the world’s only clinically-validated platform of adult-derived, pluripotent-like stem cells, backed by over 85 peer-reviewed studies and more than 120 medical publications.

• Stress-Enduring

Dezawa MuseCells™ can survive and function in harsh, highly inflamed, and oxygen-deprived (hypoxic) environments where standard MSCs may struggle to survive.

• Targeted Homing (S1P)

Injured pelvic tissues release an alerting signal, sphingosine-1-phosphate (S1P). Dezawa MuseCells™ possess specialized receptors (S1PR2) that sense this signal, actively migrating directly to the site of damage.

• Pluripotent Regeneration

Dezawa MuseCells™ can spontaneously differentiate into all three germ layers (ectoderm, mesoderm, and endoderm). They can help rebuild complex pelvic architecture, including nerve, muscle, vascular, and connective tissues.

• Non-Tumorigenic Safety

They maintain chromosomal integrity, which means they do not form teratomas (tumors), offering an unparalleled safety profile alongside high immune tolerance.

Regenerative Treatments for Pelvic Pain Versus Traditional Pain Relief Options

Early-phase outcomes and extensive clinical validation show distinct advantages for cellular therapies over conventional care for pelvic pain.

A Shifting Approach for Addressing Chronic Pelvic Discomfort

Instead of relying entirely on temporary nerve blocks or risking the complications associated with synthetic mesh implants, regenerative treatments address the root biological issue.

Utilizing your body’s innate repair mechanisms, whether through the potent signaling of MSCs or the targeted homing and rebuilding of Dezawa MuseCells™, presents a progressive strategy for reclaiming mobility and comfort.

Ideal Candidates for Pelvic Regenerative Care

Patients exploring cellular options typically have complex medical histories. You may be a strong candidate if you fall into these categories:

• Refractory cases

Individuals who have exhausted physical therapy, oral medications, and standard injections without meaningful improvement.

• Post-surgical complications

Patients experiencing lingering nerve irritation or muscular weakness following prior pelvic operations.

• Surgical avoidance

Those seeking minimally invasive alternatives to significant anatomical reconstruction or mesh placements.

• Debilitating daily symptoms

Individuals whose functional independence is severely limited by chronic pelvic pain syndrome or severe incontinence.

Explore Your Pelvic Pain Relief Options with STEMS Health in Miami

At STEMS Health in Miami, we are proud to be Florida’s premier authorized clinical partner for Dezawa MuseCell™ therapy while also offering advanced standard MSC protocols. Our double board-certified physicians,  Dr. Jarred Mait and Dr. Ankeet Choxi, collaborate with patients nationwide and around the globe to accurately assess pelvic trauma and develop customized regenerative pain relief plans.

Choose STEMS Health for:

• Comprehensive reviews of your specific musculoskeletal or neuro-inflammatory pelvic condition.

• Guidance on choosing between MSCs and clinically-validated Dezawa MuseCells™ based on your specific tissue damage.

• Seamless integration of regenerative strategies with your current rehabilitation.

Schedule your virtual consultation today to connect directly with our experienced physicians.

Common Questions About Cellular Treatments for Pelvic Pain

Which specific cells are utilized for pelvic floor repair?

Clinicians utilize either standard Mesenchymal Stem Cells (MSCs) harvested from the patient’s own adipose tissue/bone marrow, or ethically-sourced, umbilical cord-derived Dezawa MuseCells™. Both exhibit robust anti-inflammatory properties suited for muscular and fascial pain relief.

Are these biological injections a guaranteed cure for chronic pelvic pain?

Current medical literature does not classify regenerative therapies as a definitive “cure.” The primary clinical objectives are to significantly reduce localized inflammation, safely repair damaged connective tissue, and restore quality of life to levels that standard therapies have failed to achieve.

How do Dezawa MuseCells™ differ from standard MSCs or steroid injections?

Steroids strictly suppress the pain signal artificially for a short window. Standard MSCs provide an excellent biological upgrade by signaling your body to heal itself. Dezawa MuseCells™ take this a step further. They are highly resistant to cellular stress (allowing them to survive in inflamed pelvic tissue) and possess receptors to seek out tissue damage.

How long does it typically take to notice improvements after cellular injections?

Because regenerative therapies rely on biological tissue repair rather than artificially masking symptoms, relief is gradual rather than immediate. Patients often report an initial decrease in localized pelvic inflammation and pain within 4 to 6 weeks. However, the more profound structural repair of the pelvic floor muscles, nerves, and fascia continues to progress over 3 to 6 months following the injection.

What does the recovery process look like immediately following the procedure?

These treatments are typically performed as minimally invasive outpatient procedures using local anesthesia or light sedation. Patients usually experience mild localized soreness in the pelvic region for a few days.

Clinicians generally recommend resting for the first 48 hours and strictly abstaining from strenuous physical activity, heavy lifting, or aggressive pelvic floor physical therapy for 4 to 6 weeks. This resting phase ensures the newly introduced cells can effectively anchor, survive, and begin the healing cascade without mechanical disruption.

Sources:

• Frontiers in Cell and Developmental Biology: Mesenchymal Stem Cell Therapy for Chronic Pelvic Pain (https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2026.1869890/full)

• Status, Challenges, and Future Prospects of Stem Cell Therapy in Pelvic Floor Disorders (https://pmc.ncbi.nlm.nih.gov/articles/PMC7190946/)

• Stem Cells in Clinical Trials for Pelvic Floor Disorders: A Systematic Literature Review (https://pmc.ncbi.nlm.nih.gov/articles/PMC9110489/)